Bringing state of the art science and principled stewardship to performance horses, their owners, and the equine industry. Following the medical model of “do no harm”, MediVet Equine develops scientifically based biological therapeutics enabling the horse to call on its own healing ability, thus achieving its full performance potential.
WHO WE ARE
MediVet Equine provides effective, all natural, drug free products and lab services designed to optimize the overall health of performance horses. We specialize in regenerative treatments that help the body heal itself and get stronger naturally. Our products are designed to activate naturally occurring stem cells and growth factors within the horses to encourage growth. None of our products swab, or contain chemicals.
We are the original developers of ACS (Autologous Conditioned Serum), SGF 1000 RMR and Clear Scope.
Our products are safe and suitable for all performance horses.
MediVet’s technologies were developed and validated in conjunction with some of the world’s leading equine research groups. In 2006, MediVet’s research and development began in Australia with The University of Sydney. The technology was then co-developed in North America with the University of Kentucky in 2009. Over three years of R&D were conducted before commercializing the products and introducing them to the Veterinary community in 2010. MediVet Equine’s facilities are state of the art, and conform to all Good Tissue Practice (GTP) Standards. We are headquartered in Nicholasville, Kentucky where we share office and lab space with our sister company. MediVet Biologics, the world’s largest animal stem cell company. Today we are continuing research and development in partnership with the University of Kentucky, MediVet Biologics, and Tailor Made Compounding.
MEET THE TEAM
Mike Kegley | Founder
A graduate of the University of Kentucky, and a Veteran, Mike Kegley has over 30 years of experience as a C- level executive in multiple business sectors including banking, healthcare, wholesale distribution, software sales, and services delivery. With adult children involved in the racing industry, he eagerly invested in MediVet Equine, which was created in 2013 to manufacture and distribute scientifically based biological therapeutics for performance horses. Shortly after he retired from fulltime business in 2016, MediVet Equine had grown to the point it needed experienced leadership at the helm and he assumed the role of CEO in 2017. In that role he guides the salesforce, manages the company’s finances and engages with clients.
Jeremy Delk | Founder
Jeremy Delk has been a successful entrepreneur for over a decade, with a keen eye for innovative new products, technologies and unexploited market niches. He utilized the financial acumen he gained in the financial sector, with Fidelity Investments, while working in both Boston and NYC, to incorporate Delk Enterprises in 2002. With the growth of Delk Enterprises, Mr. Delk made the decision to move back to his native Kentucky focusing on the growth of his company. Over time, Mr. Delk expanded Delk Enterprises from primarily a real estate holdings firm to a diversified private equity portfolio including equity holdings in animal health, sports medicine, human health care, pharmacy & creating access to future IP through strategic investments in technology and human health R&D initiatives. Today positively disrupting healthcare through portfolio companies and other strategic investments is where his primary focus lies. His expertise and experience in the world of biological therapeutics has guided the scientific investments MediVet Equine has made and continues to make.
Michael Kegley, Jr. | Director of Sales
Michael lives in Lexington KY, where he attended the University of Kentucky. Both during and after college, he spent eight years working for Rood & Riddle Equine Hospital. At RREH, he gained valuable knowledge and experience in the care of horses, but also was afforded the opportunity to learn, and contribute, in many areas of the operation. During those years Michael also had the opportunity to work the Keeneland and Fasig Tipton Sales, as well as being an equine first responder during events at the Kentucky Horse Park. Prior to heading the sales and education arm of MediVet Equine, Michael served as General Manager of the Equine Sports Science Institute. ESSI’s team was made up of a veterinarian, an equine sport physiologist, a nutritionist, a pharmacologist, a toxicologist, and an accomplished thoroughbred trainer. They worked together to provide an evidence-based approach to thoroughbred racehorse training and management. Michael manages sales for MediVet Equine and is a subject matter expert on our products.
Benjamin Cloud | Laboratory Services
Ben is a native of Indiana with an undergraduate degree in Biology and Environmental Services from Manchester University. He recently completed his Master’s Degree from the University of Kentucky studying Wildlife Health and Behavior, during which he gained extensive experience in laboratory procedures and maintenance of laboratory equipment. Ben is a subject matter expert in Cell Culture & Aseptic Technique.